Takeda Pharmaceutical Company Limited (TAK)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 41.09B |
| Enterprise Value | 69.21B |
| Trailing P/E | 45.40 |
| Forward P/E | 23.31 |
| PEG Ratio (5 yr expected) | 3.27 |
| Price/Sales (ttm) | 1.53 |
| Price/Book (mrq) | 0.89 |
| Enterprise Value/Revenue | 2.52 |
| Enterprise Value/EBITDA | 10.75 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.54 |
| 52-Week Change 3 | -18.38% |
| S&P500 52-Week Change 3 | 26.43% |
| 52 Week High 3 | 16.58 |
| 52 Week Low 3 | 12.77 |
| 50-Day Moving Average 3 | 13.81 |
| 200-Day Moving Average 3 | 14.48 |
Share Statistics
| Avg Vol (3 month) 3 | 1.67M |
| Avg Vol (10 day) 3 | 1.49M |
| Shares Outstanding 5 | 3.14B |
| Implied Shares Outstanding 6 | 3.15B |
| Float 8 | 1.55B |
| % Held by Insiders 1 | 0.00% |
| % Held by Institutions 1 | 2.80% |
| Shares Short (Apr 15, 2024) 4 | 5.97M |
| Short Ratio (Apr 15, 2024) 4 | 3.23 |
| Short % of Float (Apr 15, 2024) 4 | N/A |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 0.19% |
| Shares Short (prior month Mar 15, 2024) 4 | 5.5M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 0.64 |
| Forward Annual Dividend Yield 4 | 4.77% |
| Trailing Annual Dividend Rate 3 | 184.00 |
| Trailing Annual Dividend Yield 3 | 1,376.22% |
| 5 Year Average Dividend Yield 4 | 4.73 |
| Payout Ratio 4 | 104.57% |
| Dividend Date 3 | Dec 11, 2023 |
| Ex-Dividend Date 4 | Sept 28, 2023 |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in JPY.Fiscal Year
| Fiscal Year Ends | Mar 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 4.28% |
| Operating Margin (ttm) | 9.44% |
Management Effectiveness
| Return on Assets (ttm) | 2.61% |
| Return on Equity (ttm) | 2.76% |
Income Statement
| Revenue (ttm) | 4.17T |
| Revenue Per Share (ttm) | 1,335.47 |
| Quarterly Revenue Growth (yoy) | 1.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | 1.21T |
| Net Income Avi to Common (ttm) | 178.22B |
| Diluted EPS (ttm) | 0.29 |
| Quarterly Earnings Growth (yoy) | -11.30% |
Balance Sheet
| Total Cash (mrq) | 288.36B |
| Total Cash Per Share (mrq) | 183.79 |
| Total Debt (mrq) | 5.21T |
| Total Debt/Equity (mrq) | 77.21% |
| Current Ratio (mrq) | 1.06 |
| Book Value Per Share (mrq) | 4,297.21 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 731.45B |
| Levered Free Cash Flow (ttm) | -9.88B |
© 2024 Yahoo. All rights reserved.